Skip to main content

Table 1 Participants characteristics at enrollment and follow-up, Mali 2015–2016

From: Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 20152016

Study arm AL (225) ASAQ (224) p-value
Participant characteristics at baseline
 Median age, month (range) 36.0 (7–59) 36.0 (6–59) 0.970
 Median weight, kg (range) 13.0 (9–21) 13.3 (9–20) 0.872
 Number male/female 126/99 111/113 0.083
 Median pre-treatment parasitemia, parasites/µL (range) 11,750 (2000–199,800) 11,825 (2000–197,500) 0.659
 Median pre-treatment hemoglobin (g/dL) 9.4 (5–13) 9.0 (5–13) 0.161
  1. AL: artemether–lumefantrine; ASAQ: artesunate–amodiaquine